Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$261M |
| 2 |
Meta Platforms (Facebook)
META
|
+$225M |
| 3 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$203M |
| 4 |
Royal Bank of Canada
RY
|
+$152M |
| 5 |
CVS Health
CVS
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$518M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$331M |
| 3 |
Thomson Reuters
TRI
|
+$266M |
| 4 |
OPTU
Optimum Communications Inc
OPTU
|
+$239M |
| 5 |
Automatic Data Processing
ADP
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.28% |
| 2 | Energy | 8.55% |
| 3 | Technology | 8.33% |
| 4 | Industrials | 8.04% |
| 5 | Healthcare | 6.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
PG&E
PCG
$39B
| $8.18M | ﹤0.01% |
177,943
-244,070
| -58% | -$10.9M |
|
1727
Nuveen Mortgage and Income Fund
JLS
$94.3M
| $8.17M | ﹤0.01% |
340,307
+17,246
| +5% | +$409K |
|
1728
Myriad Genetics
MYGN
$299M
| $8.16M | ﹤0.01% |
177,421
+166,131
| +1,471% | +$7.39M |
|
|
FFC
1729
Flaherty & Crumrine Preferred and Income Securities Fund
FFC
$780M
| $8.16M | ﹤0.01% |
447,756
-9,494
| -2% | -$180K |
|
|
BPMC
1730
DELISTED
Blueprint Medicines
BPMC
| $8.14M | ﹤0.01% |
104,347
+29,048
| +39% | +$2.02M |
|
|
DOCU
1731
DocuSign
DOCU
$11.8B
| $8.14M | ﹤0.01% |
154,838
+5,189
| +3% | +$294K |
|
1732
Stellantis
STLA
$20.1B
| $8.13M | ﹤0.01% |
460,294
+12,921
| +3% | +$228K |
|
1733
Viatris
VTRS
$18.5B
| $8.11M | ﹤0.01% |
221,960
-401,710
| -64% | -$15.1M |
|
1734
PUT
Manulife Financial
MFC
$73.6B
| $8.1M | ﹤0.01% |
453,000
-112,500
| -20% | -$2.04M |
|
1735
State Street SPDR S&P International Dividend ETF
DWX
$530M
| $8.09M | ﹤0.01% |
213,450
+25,737
| +14% | +$992K |
|
1736
Vanguard Short-Term Treasury ETF
VGSH
$30.3B
| $8.09M | ﹤0.01% |
135,380
-26,639
| -16% | -$1.59M |
|
1737
Exelixis
EXEL
$12.6B
| $8.08M | ﹤0.01% |
454,980
+41,533
| +10% | +$810K |
|
1738
PUT
Cenovus Energy
CVE
$57.7B
| $8.07M | ﹤0.01% |
805,000
+640,000
| +388% | +$6.25M |
|
1739
iShares MSCI China ETF
MCHI
$6.16B
| $8.07M | ﹤0.01% |
134,760
+40,725
| +43% | +$2.5M |
|
1740
Marten Transport
MRTN
$1.25B
| $8.05M | ﹤0.01% |
573,858
+33,231
| +6% | +$495K |
|
1741
CALL
Sun Life Financial
SLF
$45.1B
| $8.05M | ﹤0.01% |
202,500
-181,700
| -47% | -$7.27M |
|
1742
First Trust Dow Jones Global Select Dividend Index Fund
FGD
$1.61B
| $8.04M | ﹤0.01% |
320,196
+213,507
| +200% | +$5.37M |
|
1743
PUT
KB Home
KBH
$3.43B
| $8.01M | ﹤0.01% |
+335,000
| New | +$8.4M |
|
1744
CALL
Baidu
BIDU
$35.1B
| $8M | ﹤0.01% |
35,000
-7,100
| -17% | -$1.67M |
|
|
ATCO
1745
DELISTED
Atlas Corp.
ATCO
| $7.99M | ﹤0.01% |
959,497
-4,309
| -0.4% | -$38.8K |
|
|
RSX
1746
CALL
DELISTED
VanEck Russia ETF
RSX
| $7.98M | ﹤0.01% |
370,000
| – | – |
|
1747
United Therapeutics
UTHR
$21.4B
| $7.97M | ﹤0.01% |
62,629
+11,599
| +23% | +$1.43M |
|
1748
First Trust Financials AlphaDEX Fund
FXO
$1.15B
| $7.96M | ﹤0.01% |
248,855
-32,888
| -12% | -$1.06M |
|
|
1749
PUT
Sun Life Financial
SLF
$45.1B
| $7.95M | ﹤0.01% |
200,000
+100,000
| +100% | +$4M |
|
|
AYX
1750
DELISTED
Alteryx Inc
AYX
| $7.93M | ﹤0.01% |
138,616
-46,677
| -25% | -$2.38M |
|
Similar funds
Royal Bank of Canada's Q3 2018 Portfolio in Review
As of Q3 2018, Royal Bank of Canada held 7,300 positions worth $241B, up 8.1% from $223B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Royal Bank of Canada deployed $7.98B of net new capital in Q3 2018, opening 581 new positions and adding to 3,668 existing holdings. Its largest new stake was Bombardier Recreational Products: 459,399 shares worth $21.7M.
By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 22% a quarter earlier, followed by Energy and Technology.
On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $518M trimmed.
- Royal Bank of Canada's largest Q3 2018 buy was Bombardier Recreational Products: 459,399 shares worth $21.7M.
- Royal Bank of Canada added most to Vanguard Intermediate-Term Corporate Bond ETF in Q3 2018, an estimated $261M increase.
- Royal Bank of Canada's biggest Q3 2018 reduction was iShares Core S&P 500 ETF, cutting an estimated $518M.
- Royal Bank of Canada fully exited Validus Hold Ltd in Q3 2018, selling an estimated $31.8M.
- Royal Bank of Canada's ten largest holdings make up 20% of its $241B portfolio in Q3 2018.
- Royal Bank of Canada opened 581 new positions and closed 278 in Q3 2018.
- Royal Bank of Canada's portfolio value rose 8.1% quarter-over-quarter to $241B.
Based on Royal Bank of Canada's 13F filing for Q3 2018, filed 14 Nov 2018.